SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1MEF - Registration statement to add securities to prior Form F-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-21-086327
Filing Date
2021-03-18
Accepted
2021-03-18 21:02:16
Documents
13
Effectiveness Date
2021-03-18

Document Format Files

Seq Description Document Type Size
1 F-1MEF d156219df1mef.htm F-1MEF 40934
2 EX-5.1 d156219dex51.htm EX-5.1 30844
3 EX-8.2 d156219dex82.htm EX-8.2 104831
4 EX-8.3 d156219dex83.htm EX-8.3 13871
5 EX-23.1 d156219dex231.htm EX-23.1 1802
6 GRAPHIC g156219dsp01a.jpg GRAPHIC 14045
7 GRAPHIC g156219g0317121354732.jpg GRAPHIC 1843
8 GRAPHIC g156219g0318163516834.jpg GRAPHIC 822
9 GRAPHIC g156219g0318163517177.jpg GRAPHIC 832
10 GRAPHIC g156219g0318163517458.jpg GRAPHIC 936
11 GRAPHIC g156219g0318163519174.jpg GRAPHIC 2816
12 GRAPHIC g156219g0318163601357.jpg GRAPHIC 2779
13 GRAPHIC g156219latham.jpg GRAPHIC 5068
  Complete submission text file 0001193125-21-086327.txt   234797
Mailing Address SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL EAST R&D BUILDING, 3RD FLOOR 6 BEIJING WEST ROAD, TAICANG F4 215400
Business Address SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL EAST R&D BUILDING, 3RD FLOOR 6 BEIJING WEST ROAD, TAICANG F4 215400 86 512 5357 7866
Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-1MEF | Act: 33 | File No.: 333-254476 | Film No.: 21756231
SIC: 2834 Pharmaceutical Preparations